Company: PTHS
Filing Date: 2025-09-16
Form Type: 8-K/A
Source: 0001753926-25-001500
Chunk: 94

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-09-16
Form: 8-K/A
Chunk 94
---
 on our board of directors; |

| • | overseeing                                                               
 the process of evaluating the performance of our board of directors; and |

| • | advising                                                      
 our board of directors on other corporate governance matters. |

Involvement in Certain Legal Proceedings

None.

Code of Business Conduct and Ethics

We have a written code of conduct and ethics that applies to our directors, officers, employees and contractors, including our principal executive officer, principal financial officer, principal accounting officer or controller, and persons performing similar functions. The code of conduct and ethics is available on our website at https://pelthos.com. We intend to disclose future amendments to such code, or any waivers of its requirements, applicable to any principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions or our directors on our website identified above or in a Current Report on Form 8-K that we would file with the SEC.

Delinquent Section 16(a) Reports

Under the securities laws of the United States, our directors, executive (and certain other) officers, and any persons holding ten percent or more of our Common Stock must report on their ownership of the Common Stock and any changes in that ownership to the SEC. Specific due dates for these reports have been established. During the fiscal year ended December 31, 2024, all reports required to be filed by such persons pursuant to Section 16(a) were filed on a timely basis.

Compensation Committee Interlocks and Insider Participation

In
connection with the closing of the Merger, the board of directors selected members of the compensation committee, each of whom
is a “non-employee” director within the meaning of Rule 16b-3 of the rules promulgated under the Exchange Act
and independent within the meaning of the independent director guidelines of the NYSE American. None of the Company’s executive
officers serves as a member of the board of directors or compensation committee of any entity that has one or more executive officers
who is proposed to serve on the board of directors or compensation committee.

Non-Employee Director Compensation

In connection with closing of the Merger, it is expected that our board of directors will adopt a non-employee director compensation policy designed to enable the Company to attract and retain, on a long-term basis, highly qualified non-employee directors and align its directors’ interests with those of its stockholders. Employee directors will not receive additional compensation for their services as directors. It is expected that each director who is not an employee